Retrospective Analysis of Rechallenge with Ipilimumab in Patients with Metastatic Melanoma

BACKGROUND: Checkpoint inhibitors are effective in the treatment of several types of cancer, either being used separately or in combination. Ipilimumab pioneered the treatment of metastatic melanoma, and nowadays, it has been used more frequently in combination with anti-PD-1. Since the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Formozo, A. A., Gomes, J. R., Schmerling, R. A., Buzaid, A. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275418/
https://www.ncbi.nlm.nih.gov/pubmed/34285817
http://dx.doi.org/10.1155/2021/5531864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275418/
https://www.ncbi.nlm.nih.gov/pubmed/34285817
http://dx.doi.org/10.1155/2021/5531864

Ejemplares similares